Literature DB >> 20470300

High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients.

Ching-Wei Hsu1, Ja-Liang Lin, Dan-Tzu Lin-Tan, Tzung-Hai Yen, Kuan-Hsing Chen, Wen-Hung Huang, Tai-Chin Ho, Yen-Lin Huang.   

Abstract

AIM: Chronic inflammation, which is common in dialysis patients, often causes malnutrition and even protein-energy wasting. However, the association of high-calcium dialysate with malnutrition and/or inflammation in non-diabetic maintenance haemodialysis patients remains unclear. This study investigated the possible adverse effects of high-calcium dialysate and mortality in this population.
METHODS: A total of 717 non-diabetic haemodialysis patients participated in this 2 year prospective study. The subjects were categorized into three subgroups based on whether dialysate calcium concentrations were high (3.5 mEq/L), standard (3.0 mEq/L) or low (2.5 mEq/L). Demographic, haematological, nutritional and inflammatory markers, biochemical and dialysis-related data were obtained for cross-sectional analysis. Causes of death and mortality rates were also analyzed for each subgroup.
RESULTS: Patients with high-calcium dialysate (n = 82) had a higher incidence of malnutrition and inflammation (61.0% vs 44.1% and 43.9%, respectively) than those with standard- and low-calcium dialysate (n = 528 and 107). Backward stepwise multiple regression analysis revealed that high-calcium dialysate was negatively correlated with nutritional index, serum albumin levels, but positively associated with the inflammatory marker of serum ferritin levels. At the end of the 2 year follow up, 45 patients had died. Cox multivariate analysis demonstrated that high-calcium dialysate was a significant associated factor (relative risk 2.765; 95% confidence interval 1.429-5.352) for 2 year all-cause mortality in these patients.
CONCLUSION: The analytical results indicate that high-calcium dialysate is associated with malnutrition and inflammation as well as 2 year mortality in non-diabetic maintenance haemodialysis patients and the findings suggest that this population, even those with optimal mineral balance, should avoid high-calcium dialysate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470300     DOI: 10.1111/j.1440-1797.2009.01202.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  4 in total

1.  Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.

Authors:  Matteo Ruggeri; Antonio Bellasi; Filippo Cipriani; Donald Molony; Cynthia Bell; Domenico Russo; Biagio Di Iorio
Journal:  J Nephrol       Date:  2014-07-16       Impact factor: 3.902

2.  Impact of living environment on 2-year mortality in elderly maintenance hemodialysis patients.

Authors:  Wen-Hung Huang; Ja-Liang Lin; Dan-Tzu Lin-Tan; Kuan-Hsing Chen; Ching-Wei Hsu; Tzung-Hai Yen
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

3.  The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients.

Authors:  Anastasia Markaki; John Kyriazis; Kostas Stylianou; George A Fragkiadakis; Kostas Perakis; Andrew N Margioris; Emmanuel S Ganotakis; Eugene Daphnis
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

4.  Impact of Dialysate Calcium Concentration on Clinical Outcomes in Incident Hemodialysis Patients.

Authors:  Hyung Wook Kim; Su-Hyun Kim; Young Ok Kim; Dong Chan Jin; Ho Chul Song; Euy Jin Choi; Yong-Lim Kim; Yon-Su Kim; Shin-Wook Kang; Nam-Ho Kim; Chul Woo Yang; Yong Kyun Kim
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.